We suggest that this ability of TDQ to provide multifaceted actions in the IR of type 2 diabetes can be attributed to its biological actions associated with PPARγ activation and DGAT2 inhibition. This evidence concerns the gene DGAT2 and type 2 diabetes mellitus.